Harbor Capital Advisors »

Stoke Therapeutics shares owned by Harbor Capital Advisors

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Harbor Capital Advisors from 13F filings

Historical chart of Harbor Capital Advisors investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Harbor Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Harbor Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $354k 11k 32.55

More positions owned by Harbor Capital Advisors

Ishares Inc core msci emkt (IEMG)
Amazon (AMZN)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Facebook Inc cl a (META)
Netflix (NFLX)
Ishares Tr usa min vo (USMV)
JPMorgan Chase & Co. (JPM)
Consumer Staples Select Sect. SPDR (XLP)
Franklin Templeton Etf Tr ftse japan etf (FLJP)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
Technology SPDR (XLK)
Cisco Systems (CSCO)

View all positions for Harbor Capital Advisors

Top funds holding Stoke Therapeutics

FMR
Rtw Investments
BlackRock
Lynx1 Capital Management
Redmile Group
Morgan Stanley
Baker Bros. Advisors
Toronto-Dominion Bank
Vanguard Group
BVF
State Street Corporation
Vanguard Capital Management
Siren
Deerfield Management Company
Henderson Group

View all funds holding Stoke Therapeutics